Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Merck & Co., Inc.    MRK

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Stock Pick
Merck and Company : Leader in oncology, modest valuation
With $46 billion in expected revenue this year, the American company Merck ranks sixth among the world's major pharmaceutical groups, behind J&J .
More Recommendations
Stock Trading Strategies
MERCK & CO., INC. - 2020
The underlying trend is to the upside
BUY
MERCK & CO., INC. - 2020
Buyers are coming back
BUY
MERCK & CO., INC. - 2020
The trend should regain control
BUY
MERCK & CO., INC - 2020
In an accumulation phase
BUY
MERCK & CO., INC - 2020
Good timing to go long again
BUY
More Stock Trading Analysis
Upcoming event on MERCK & CO., INC.
02/04/21FY 2020 Earnings Call
Upcoming sector events
01/26/21JOHNSON & JOHNSON : FY 2020 Earnings Release
01/26/21NOVARTIS AG : FY 2020 Earnings Release
01/28/21LUPIN LIMITED : Q3 2021 Earnings Release
01/28/21SUMITOMO DAINIPPON PHARMA CO., LTD. : Q3 2020 Earnings Release
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Categories
Free services
Mobile App
SOLUTIONS
About
Stock Market Quotes Interactive brokers The best of tweets Stock Market News Börse: Aktien, Kurse und Nachrichten
Copyright © 2021 Surperformance. All rights reserved. Stock quotes are provided by Factset, Morningstar and S&P Capital IQ